Align Technology settles patent litigation with Ormco Align Technology.

Related StoriesLife Technologies reviews third quarter 2009 results; non-GAAP and organic revenues increase by 3 percent and 5 percentDanaher acquires Life Technologies' mass spectrometry businessDanaher to acquire Beckman Coulter for $83.50 per shareAlign and Ormco also have agreed upon a special collaboration over another seven years to develop and market an orthodontic item that combines the Invisalign system with Ormco’s Insignia orthodontic brackets and arch wires system to treat the most complex cases. Each ongoing party will maintain possession of its pre-existing intellectual real estate, and each ongoing party will be granted intellectual residence licenses in their particular field for jointly-developed combination products.Furthermore, the shorter interval between a reported bout of serious hypoglycemia and loss of life than between such an episode and a macrovascular event suggests that among individuals with severe hypoglycemia, those who died were sicker at the time of their episode of hypoglycemia than those who had other types of events. In both the ADVANCE study and the ACCORD research,14 annual mortality among individuals who reported severe hypoglycemia was higher in the group receiving standard treatment than in the group receiving intensive treatment. Despite the higher rate of severe hypoglycemia in the latter group, hypoglycemia was not considered to be a likely explanation for the surplus mortality associated with intensive control in the ACCORD trial.